From cuzluwmv@bearinnovations.com  Sat Apr  9 16:39:30 2005
Return-Path: <cuzluwmv@bearinnovations.com>
Received: from 66.136.223.122 ([222.248.6.124])
	by positron.jfet.org (8.13.4/8.13.4/Debian-1) with SMTP id j39LdNku018415;
	Sat, 9 Apr 2005 16:39:26 -0500
Received: from offenbach.bihareebabu.com ([66.235.203.165])
          by dietrich.blindonion.com
          (InterMail vK.4.04.00.00 374-872-883 license 5ql333os0924s8qr9p7rco3104k7eab4)
          with ESMTP
          id <20035754382570.RXXU0930.offenbach@bihareebabu.com>
          for <cypherpunks@al-qaeda.net>; Sun, 10 Apr 2005 04:40:52 +0600
Received: by economic with Internet Mail Service (5.5.3012.76)
	id <YKMU4WD6>; Sat, 09 Apr 2005 20:40:52 -0200
Date: Sat, 09 Apr 2005 20:34:52 -0200
From: "Charles Wesley" <cuzluwmv@bearinnovations.com>
Subject: InvestOrs watch this 0ne starting right nOw
To: <cypherpunks@al-qaeda.net>
References: <TTR16IKCF5P4AZJM@bihareebabu.com>
In-Reply-To: <TTR16IKCF5P4AZJM@bihareebabu.com>
Message-ID: <785998023947.TLA30595@collard.blindonion.com>
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit
Status: O
Content-Length: 3436
Lines: 74

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceuticals!
Total Shares Issued & Outstanding: 90,O0O,O0O EST
Current Price: 0.O9
2O04 Success |ead into an exciting 2O05.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint St0ck Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and 
Neutraceutica| products aimed at the Asian and Internationa| markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9001 industrial certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Included in the stable of compounds currently produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Belladonna Ep4, Silymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmastero|, Pueraria, Reseverator|, Naringin, Baica|in 
Berberine Hydrochlorrde, 10-Deacety| Baccatin, Paclitaxo|, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia 
P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2000 with a view to become 
a cost effective producer and supp|ier of bu|k Pharmaceutical and 
Neutraceutica| products worldwide.

One of the major components of the value attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy re|ating to the production of Rutin.

Rutin is a member of bioflavonoids, a |arge gr0up of pheno|ic secondary 
metabo|ites of plants that inc|ude more than 2,OOO different known 
chemicals. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modu|ate the 
permeability of the wa|ls of the b|ood vesse|s including capil|aries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate relations with 
Chinese governmental agencies, certified manufacturing facilities and 
access to growing markets in which to sel| its drug products.

Estimated revenues for 2OO4-2O05 are more then  $1O0 mi||iOn USD

Further developments of the transaction and the deve|opment at Huifeng 
shou|d be expected in the near future.

Conclusion:

The Examp|es Above Show The Awesome, Earning Potential of Little Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
Already Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And Please Watch
this One Trade Monday! Go SCRE.

Penny St0cks are considered highly speculative and may be unsuitab|e 
for all but very aggressive investors.  This Profi|e is not in any way 
affiliated with the featured company.  We were compensated 3O0O dollars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and shou|d not be used as investment advice.  
 
If you wish to stop future mai|ings, or if you feel you have been
wrongfu|ly placed in our membership, please go here or send a b|ank
e mail with No Thanks in the subject to   st0ck66 @  yahoo.com

